Skip to content

Clinical study of ginkgo ketone ester tablets combined with atorvastatin calcium in the treatment of sputum turbidity suppression of hypercholesterolemia

Clinical study of ginkgo ketone ester tablets combined with atorvastatin calcium in the treatment of sputum turbidity suppression of hypercholesterolemia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037707
Enrollment
Unknown
Registered
2020-08-30
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperchlesterolaemia

Interventions

Sponsors

Shanghai Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.It meets the diagnostic criteria of hyperlipidemia in western medicine; 2.It conforms to the above diagnostic criteria of TCM phlegm-turbidity block syndrome; 3.Age between 18 and 70 years old, and independent behavior ability; 3.Understand the whole process of this study, and informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Patients with severe complications of the disease, or with other severe primary diseases, or allergic constitution and multiple drug allergies; 3.Poor compliance, loss of follow-up or inability to provide relevant materials; 4.They also received other clinical trials.

Design outcomes

Primary

MeasureTime frame
triglyceride;total cholesterol;high density lipoprotein cholesterol;low density lipoprotein cholesterol;

Countries

China

Contacts

Public ContactHuang Hui

Shanghai Traditional Chinese Medicine Hospital

hh553221789@sina.com+86 15952013739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026